Acute-Phase Serum Amyloid A as a Marker of  Insulin Resistance in Mice by Scheja, Ludger et al.
Hindawi Publishing Corporation
Experimental Diabetes Research
Volume 2008, Article ID 230837, 11 pages
doi:10.1155/2008/230837
ResearchArticle
Acute-Phase Serum Amyloid A as a Marker of
Insulin Resistance in Mice
Ludger Scheja,1,2 Barbara Heese,1,2 Heike Zitzer,2 Mervyn D. Michael,3 Angela M. Siesky,3
Heike Pospisil,4 Ulrike Beisiegel,1 and Klaus Seedorf1,2
1Department of Biochemistry and Molecular Biology II, University Medical Center, 20246 Hamburg, Germany
2Former Lilly Research Laboratories, 22419 Hamburg, Germany
3Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA
4Center for Bioinformatics, University of Hamburg, 20146 Hamburg, Germany
Correspondence should be addressed to Ludger Scheja, l.scheja@uke.uni-hamburg.de
Received 21 November 2007; Revised 3 March 2008; Accepted 29 April 2008
Recommended by Eleazar Shafrir
Acute-phase serum amyloid A (A-SAA) was shown recently to correlate with obesity and insulin resistance in humans. However,
the mechanisms linking obesity-associated inﬂammation and elevated plasma A-SAA to insulin resistance are poorly understood.
Using high-fat diet- (HFD-) fed mice, we found that plasma A-SAA was increased early upon HFD feeding and was tightly
associated with systemic insulin resistance. Plasma A-SAA elevation was due to induction of Saa1 and Saa2 expression in liver
but not in adipose tissue. In adipose tissue Saa3 was the predominant isoform and the earliest inﬂammatory marker induced,
suggesting it is important for initiation of adipose tissue inﬂammation. To assess the potential impact of A-SAA on adipose tissue
insulin resistance, we treated 3T3-L1 adipocytes with recombinant A-SAA. Intriguingly, physiological levels of A-SAA caused
alterations in gene expression closely resembling those observed in HFD-fed mice. Proinﬂammatory genes (Ccl2, Saa3)w e r e
induced while genes critical for insulin sensitivity (Irs1, Adipoq, Glut4) were down-regulated. Our data identify HFD-fed mice
as a suitable model to study A-SAA as a biomarker and a novel possible mediator of insulin resistance.
Copyright © 2008 Ludger Scheja et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
An important aspect of obesity-linked insulin resistance is
chronic, subclinical inﬂammation taking place in adipose
tissue and other major metabolic tissues. Local activation
of proinﬂammatory pathways results in the suppression of
insulin signaling thereby contributing to impaired glucose
metabolism (see [1] for a recent review). The molecular
and cellular mechanisms linking obesity-associated inﬂam-
mation to insulin resistance are under intense investigation.
Within these studies, plasma inﬂammation markers such as
acute-phase proteins [2] draw special attention as they are
important both for understanding the relative contribution
of inﬂammation to insulin resistance and their immediate
biological activities on insulin signaling as well as for the
development of clinical biomarkers.
One acute-phase protein reported to be increased in
plasma of obese and insulin resistant humans is serum
amyloid A (SAA) (reviewed in [3]). Acute-phase SAA (A-
SAA) consists of two closely related isoforms, SAA1 and
SAA2, which can be induced over a wide expression range in
response to proinﬂammatory stimuli. Additional members
of the SAA family are SAA3 and SAA4 [3]. SAA3 is expressed
in mice and other mammalian species but apparently not in
humans who have a defective Saa3 gene [4]. SAA3 is also
induced under proinﬂammatory conditions and may share
physiological functions with the A-SAA isoforms. SAA4 is a
constitutively expressed member of the family and responds
only moderately to inﬂammatory stimuli.
Chronic systemic elevation of A-SAA has been linked
to metabolic disease and is a well-established risk factor of
atherosclerosis [5–7]. It also appears to correlate with insulin
resistance and body mass index in humans, as demonstrated
in recent studies. A-SAA levels in patients fell when either
fat mass was reduced or insulin sensitivity was restored
by treatment with a PPARγ agonist [8–10]. Interestingly,
although liver is the organ believed to be most important
for A-SAA secretion in the acute-phase response, in insulin
resistance-related human studies Saa1 and Saa2 expression
was higher in adipose tissue than in liver [9, 11, 12]a n d2 Experimental Diabetes Research
also the correlation of A-SAA gene expression with plasma
levels was higher in this tissue [11]. Thus, it appears that the
regulation of A-SAA in the context of obesity and insulin
resistance has some unique features as compared to the
acute-phase response. A-SAA induction in that context is
triggered primarily by cytokines such as interleukin (IL)-1
and tumor necrosis factor-a (TNF a), but also by IL-6 and
related cytokines [2, 13].
In addition to their biomarker properties, SAA iso-
forms may also be causally involved in the development
of metabolic diseases. In the case of atherosclerosis, a
couple of mechanisms have been proposed. A-SAA is an
apolipoprotein predominantly associated with high-density
lipoprotein (HDL) particles and, when increased, it can
inﬂuence antiatherogenic functions of HDL, especially such
involving cholesterol uptake and eﬄux [14–16]. Also, as
shown in mice, A-SAA binds to atherosclerotic lesions and,
thereby, may cause retention of lipoproteins and lipid depo-
sition [17]. Biological functions of A-SAA potentially con-
tributing to both atherosclerosis and insulin resistance are
proinﬂammatory properties normally involved in pathogen
defenseandtissuerepairsuchaschemotaxis,cytokineinduc-
tion, and the secretion of extracellular matrix-degrading
proteases [18–20]. Chronic activation of these inﬂammatory
processes may lead to inﬁltration of immune cells into the
tissues. In obesity, massive inﬁltration of adipose tissue by
macrophages takes place which can be detected through
increased expression of myeloid cell markers such as F4/80,
CD68, and CD11b [21, 22]. This inﬁltration is believed to
be triggered by increased secretion by adipose tissue cells of
chemoattractant molecules including the chemokine CCL2
(also known as MCP1) [23]. Accumulation of activated
macrophages leads to sustained production of proinﬂamma-
tory mediators, entailing adipocyte insulin resistance, and
deteriorated glucose metabolism.
Studies relating to A-SAA induction in rodents have been
performed in mouse atherosclerosis models and have oﬀered
valuable clues regarding A-SAA regulation by lipids [24–
26]. However, they were not designed to study defects or
mechanisms relating to glucose homeostasis. In order to
addresstheroleofSAAinglucosemetabolism,wedesigneda
study using a common model of insulin resistance, the diet-
induced obesity (DIO) mouse. We induced distinct degrees
ofoverweightandinsulinresistancebyfeedingahigh-fatdiet
(HFD) for diﬀerent periods of time and compared plasma A-
S A Al e v e l sa n de x p r e s s i o no fS A Ai s o f o r m sw i t hp a r a m e t e r s
of insulin sensitivity and inﬂammation in liver, adipose
tissue and muscle. Furthermore, using cultured adipocytes
we investigated whether A-SAA may directly promote the
expression of proinﬂammatory genes and interfere with
insulin signaling.
2. MATERIALS AND METHODS
2.1. Materials
Recombinant A-SAA was obtained from Peprotech (Ham-
burg, Germany). DMEM, BSA, and calf serum were from
Invitrogen (Karlsruhe, Germany). FCS was from Biochrom-
Seromed (Berlin, Germany). All other reagents (mouse
TNFα, insulin, dexamethasone, IBMX, LPS, PMB) were
purchased from Sigma-Aldrich (Munich, Germany).
2.2. Animaldietregimensandnecropsy
Age-matched male C57Bl/6 mice (Taconic, Germantown,
NY) on distinct diets were used as models of insulin
resistance and as the respective controls. Severe insulin
resistance and obesity were induced by weaning animals on
an HFD (Bioserv3282, 59 cal% fat) and maintaining them
on the diet for 16 weeks. Mildly insulin-resistant mice were
generated by randomizing lean mice based on fasting plasma
glucose and insulin, and subsequently feeding one group the
HFD for one week while the other mice were kept as controls
on a standard rodent chow (Purina5001).
Forrandomization,animalswerebledbytailclipmethod
at 19 weeks of age after overnight fast. At 20 weeks of age,
all mice were subjected to necropsy. The animals were fasted
overnight (16 hours), anesthetized with isoﬂurane, and
cardiac stick was performed to collect blood as EDTA plasma
from the right ventricle of the heart. After bleeding, the
animals were perfused (10U/L heparinized saline) through
the right ventricle of the heart, allowing the blood to exit the
animal through a cut in the inferior vena cava. Organs were
then removed. Selected organs and blood were snap frozen
in liquid nitrogen and stored at −80◦C.
Animals were maintained on a 12-hour light, 12-hour
dark cycle and received house water ad libitum. All animals
were kept in accordance with the Institutional American
Association for the Accreditation of Laboratory Animal Care
guidelines.
2.3. Plasmaparameters
Plasma insulin was determined using Rat/Mouse Insulin
Assay kit (Mesoscale Discovery, Gaithersburg, Md) and
Mouse Endocrine Lincoplex kit (Millipore, St. Charles, Mo)
for randomization and ﬁnal study, respectively. Glucose was
measured using a Hitachi 912 clinical chemistry analyzer
(Roche, Indianapolis, Ind). Adiponectin and A-SAA were
determined using ELISAs from R&D Systems (Minneapolis,
Minn) and Biosource (Invitrogen), respectively.
2.4. TotalRNAextractionandreal-time
quantitativePCR
TotalRNAfromfrozentissuesampleswasextractedusingthe
TissueLyser and RNeasy system (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions (RNeasy Lipid
Tissue Kit and RNeasy Fibrous Tissue Kit for adipose and
muscle tissue, resp.). DNA contaminants were removed via
column DNase treatment (RNase-Free DNase set; Qiagen).
1μg of RNA was reversely transcribed in a 50μLr e a c t i o n
mixture using the High Capacity cDNA Archive Kit (Applied
Biosystems, Darmstadt, Germany) according to the man-
ufacturer’s instructions. Real time RT-PCR was performed
as described previously [27]. For detections of Saa2 andLudger Scheja et al. 3
Irs2, Assay-by-Design Assay that mixes with the following
sequences was used:
Irs2-fwd GCGGCCTCATCTTCTTCACT,
mIrs2-rev AACTGAAGTCCAGGTTCATATAGTCAGA,
mIrs2-Pr CGACAGCCGGCAGCGCTCTC,
mSaa2-fwd GAGTCTGCCATGGAGGGTTTT,
mSaa2-rev TGTAGGCTCGCCACATGTC,
mSaa2-Pr TCCAGCCCCTTGGAAAG.
For all other genes Assay-on-Demand primer/probe
sets supplied by Applied Biosystems were used (Assay
IDs are available upon request). Relative expression was
calculated by normalization to selected house keeper mRNA
(cyclophilin E for muscle, TBP for all others) by ΔΔCt
method [28]. Data are reported as copy number relative to
104 copies of house keeper.
2.5. Differentiationandtreatmentof
3T3-L1adipocytes
3T3-L1 cells were maintained in DMEM containing 10%
calf serum. To diﬀerentiate, cells were grown to conﬂuence,
switchedtodiﬀerentiationmedium(DMEM,4.5g/Lglucose,
supplemented with 10% FCS, 5μg/mL insulin, 0.25μM
dexamethasone, 0.5mM IBMX), and cultured for 2 days.
Subsequently, cells were kept in diﬀerentiation medium
without dexamethasone and IBMX for 3 days and further
diﬀerentiated in medium also lacking insulin for at least 1
week before experimentation. Before treatment, cells were
washed once with PBS and starved overnight in DMEM,
1g/L glucose, containing 0.1% BSA. Reagents were then
added directly to wells.
2.6. Statisticalanalysis
Unless indicated otherwise two-tailed Student’s t-test was
used to assess statistical signiﬁcance between groups. Pear-
son’s correlation test was used to evaluate the degree and
the signiﬁcance of association between plasma A-SAA and
obesity or insulin resistance parameters.
3. RESULTS
3.1. High-fatdietfeedinginducesinsulinresistance
andincreasesplasmaA-SAAlevels
One week HFD (1 w HFD) feeding of mice resulted in
enhanced body weight (27.0 ± 0.7g versus 23.0 ± 0.5g,
mean ± SEM, P<. 001) and induced signiﬁcant fasting
hyperinsulinemia and hyperglycemia compared to controls
maintained on chow diet (see Figure 1), indicating mild
insulin resistance already after a short period on the obesi-
genicdiet.Asexpected,16weeksofHFD(16wHFD)feeding
l e dt om o r ep r o n o u n c e do v e r w e i g h t( 4 4 .9 ± 0.7g;P<. 001
versus controls) and insulin resistance compared to controls
(see Figure 1). Plasma leptin showed a similar pattern (19
± 5pmol/L, control, 130 ± 25pmol/L, 1w HFD, 1205 ±
194pmol/L, 16w HFD; P<. 001).
Plasma A-SAA was elevated in the 1w HFD group (see
Figure 1;5 .06±1.05μg/mL versus 2.11±0.25μg/mL in con-
trol animals, P<0.05) and increased substantially further
in the 16 w HFD group (31.4 ± 7.0μg/mL, P<. 01 versus
controls), demonstrating that the plasma levels of A-SAA are
associated with obesity and insulin resistance in a quanti-
tative fashion. This quantitative association was conﬁrmed
by combining all experimental groups and performing a
correlation analysis for plasma A-SAA (Pearson correlation
coeﬃcients: 0.76, insulin; 0.75, glucose; 0.84, HOMA-IR;
0.78, leptin; P<. 001). In contrast, plasma adiponectin
levels were not aﬀected by 1 w HFD, however, they were
signiﬁcantly reduced after 16 w HFD (see Figure 1).
3.2. Tissue-speciﬁcinductionofSAAisoforms
In order to understand the contribution of key metabolic
tissues to the observed A-SAA induction in plasma, we
performed real-time quantitative PCR experiments in liver,
adipose tissue, and skeletal muscle. As shown in Figure 2 and
Table 1, both A-SAA isoforms, Saa1 and Saa2, were highly
expressed in liver and were induced by short- and long-term
HFD feeding (P<. 15 for 1w HFD). Saa3 was also well
expressed in liver, however, it was not signiﬁcantly induced
in this tissue by the HFD. By contrast, Saa3 was strongly
expressed in adipose tissue and markedly induced already
after one week of HFD with no further increase observed
after16weeks(seeFigure 2).Interestingly,expressionofSaa1
and Saa2 was very low in adipose tissue (see Table 1)a n d
neither of them was induced by the HFD indicating that
adipose tissue is not involved in the elevation of plasma A-
SAA by the HFD. In skeletal muscle basal expression of all
SAA isoforms was very low. While the mRNA expression of
Saa1 and Saa2 was not aﬀected by HFD, Saa3 was markedly
induced after 16 weeks of HFD (see Table 1).
The cytokines IL-1β,I L - 6 ,a n dT N F α are established as
important inducers of Saa1 and Saa2 in liver during the
acute-phase response. In order to assess the role of these
cytokines in Saa1 and Saa2 induction upon HFD feeding, we
quantiﬁed also their expression. In liver, the mRNAs of both
IL-1β and TNFα (Il1b, Tnf) were increased after 16 w HFD
feeding. In contrast, neither cytokine was induced after 1 w
HFD feeding, suggesting that they are not responsible for the
early elevation of plasma A-SAA (see Figure 2).
In adipose tissue, Tnf was strongly induced after 16
weeks of HFD, however, only a trend toward an increase
was observed in the 1 w HFD group. The expression level of
Il1b in adipose tissue was not signiﬁcantly changed by HFD
feeding (see Figure 2).
The mRNA of IL-6 (Il6) was not induced in any of the
tissues examined in a statistically signiﬁcant manner (see
Figure 2 and Table 1).
3.3. AssociationofA-SAAlevelswithinductionof
macrophagemarkersandchemoattractant
moleculesininsulintargettissues
The observed tissue- and isoform-selective patterns of SAA
expression in response to the high-fat diet prompted us to
further characterize the underlying inﬂammatory processes.
To this end, we assessed the expression of inﬂammatory4 Experimental Diabetes Research
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Figure 1: (a) Fasting plasma insulin, (b) glucose, (c) adiponectin, and (d) A-SAA levels in mice fed either control diet (Chow), control diet
for 15 weeks, and HFD for one week (1 w HFD), and HFD for 16 weeks (16 w HFD), respectively. Bar graphs are presented as mean ±SEM
(n = 5–8), statistics: ∗P<. 05 versus Chow, ∗∗P<. 01 versus Chow, (a)P<. 05 versus 1w HFD, (b)P<. 01 versus 1w HFD; Mann-Whitney
U-Test was used for insulin (7/8 measurements in Chow group were below detection level, 56pmol/L); two-tailed Student’s t-test for all
other measurements.
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Figure 2: (a), (b) Diet-induced expression of SAA isoforms and (c), (d) SAA inducers in (a), (c) liver and (b), (d) adipose tissue, quantiﬁed
by real-time quantitative PCR. Data are mean ±SEM normalized to control animals (fold over Chow). Number of animals (n), see Table 1.
Statistics: ∗P<. 05 versus Chow, ∗∗P<. 01 versus Chow, (a)P<. 05 versus 1w HFD, (b)P<. 01 versus 1w HFD; two-tailed Student’s t-test.Ludger Scheja et al. 5
Table 1: Expression of SAA isoforms and SAA inducers in liver, adipose tissue and skeletal muscle of HFD-fed mice. Data are reported as
copy numbers relative to 104 copies of house keeper. Numbers of animals (n) are in parentheses. Data are mean ±SEM; ∗P<. 05 versus
Chow, ∗∗P<. 01 versus Chow, (a)P<. 05 versus 1w HFD, (b)P<. 01 versus 1w HFD; two-tailed Student’s t-test.
Experimental Groups Chow 1w HFD 16w HFD
Copy number Copy number Copy number
Liver
Saa1 20,885 ± 3,746 (5) 80,450 ± 27,367 (6) 168,070 ± 24,441 (5)∗∗(a)
Saa2 96,460 ± 16,927 (5) 370,729 ± 150,376 (6) 998,406 ± 164,697 (5)∗∗(a)
Saa3 18,824 ± 4,753 (6) 16,098 ± 3,374 (6) 31,641 ± 7,118 (6)
Il1b 1,216 ± 138 (6) 813 ± 87 (6)∗ 1,885 ± 255 (6)∗(b)
Il6 30 ± 5 (6) 22 ± 4 (6) 21 ± 3( 6 )
Tnf 296 ± 65 (6) 339 ± 51 (6) 1,159 ± 142 (6)∗∗(b)
Adipose tissue
Saa1 262 ± 86 (6) 70 ± 21 (6) 78 ± 17 (6)
Saa2 1,544 ± 1,035 (5) 615 ± 170 (4) 355 ± 75 (5)
Saa3 5,566 ± 1,086 (5) 60,924 ± 25,363 (4)∗ 48,600 ± 14,279 (5)∗
Il1b 261 ± 88 (5) 97 ± 21 (4) 384 ± 142 (5)
Il6 253 ± 105 (6) 139 ± 24 (6) 618 ± 352 (6)
Tnf 648 ± 189 (6) 1,015 ± 119 (6) 6,009 ± 488 (6)∗∗(b)
Skeletal muscle
Saa1 24 ± 4 (6) 23 ± 6 (6) 36 ± 4( 6 )
Saa2 92 ± 18 (6) 75 ± 12 (6) 96 ± 16 (6)
Saa3 44 ± 21 (6) 65 ± 23 (6) 1,196 ± 210 (6)∗∗(b)
Il1b 34 ± 6 (6) 41 ± 8 (6) 45 ± 5( 6 )
Il6 88 ± 10 (6) 96 ± 13 (6) 56 ± 5( 6 ) ∗(a)
Tnf 60 ± 20 (6) 115 ± 30 (6) 122 ± 7( 6 ) ∗
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Figure 3: (a) Diet-induced expression of inﬂammatory genes in liver and (b) adipose tissue, quantiﬁed by real-time quantitative PCR. Data
are mean ±SEM normalized to control animals (fold over Chow). Number of animals (n), see Table 2. Statistics: ∗P<. 05 versus Chow,
∗∗P<. 01 versus Chow, (a)P<. 05 versus 1 w HFD, (b)P<. 01 versus 1 w HFD, two-tailed Student’s t-test.
markers including the chemoattractant molecules CCL2
and CXCL1 (also known as KC) as well as macrophage
inﬁltration markers (CD68, CD11b, F4/80). As shown in
Figure 3 and Table 2, one week feeding of HFD slightly
induced the expression of the chemokine genes (Ccl2, Cxcl1)
in liver (P<. 15) while neither chemokine was increased
in adipose tissue and only Ccl2 was induced in muscle.
The genes of the myeloid cell markers CD68, CD11b, and
F4/80 (Emr1) were moderately but signiﬁcantly induced
in adipose tissue after one week of HFD, demonstrating6 Experimental Diabetes Research
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Figure4:(a)Diet-inducedexpressionofgenesrelatedtoinsulinsensitivityinliverand(b)adiposetissue,quantiﬁedbyreal-timequantitative
PCR. Data are mean ± SEM normalized to control animals (fold over Chow). Number of animals (n), see Table 2. Statistics: ∗P<. 05 versus
Chow, ∗∗P<. 01 versus Chow, (a)P<0.05 versus 1 w HFD, (b)P<. 01 versus 1 w HFD, two-tailed Student’s t-test.
incipient adipose inﬁltration by macrophages, while in the
othertissuessigniﬁcantinductionofthesemarkerscouldnot
be observed, except for Cd68 in liver.
After 16 weeks of HFD, pronounced expression of
inﬂammatory markers was observed in all tissues examined
(see Figure 3 and Table 2). The macrophage markers Cd68,
Cd11b,andEmr1 werehighlyinducedinadipose,moderately
increased in muscle, while in liver only Cd68 was induced
signiﬁcantly.
Taken together, the temporal expression pattern of liver
Ccl2, Cxcl1,a n dCd68 as well as adipose tissue Cd68, Cd11b,
and Emr1 corresponded to liver Saa1 and Saa2 mRNA,
plasma A-SAA protein, and insulin resistance in our exper-
iment. Interestingly, none of the inﬂammatory markers in
adipose tissue showed an expression pattern similar to Saa3.
3.4. Reducedexpressionofgenesimplicatedin
insulinsensitivityinliver,adiposetissue,and
skeletalmuscleofHFD-fedmice
Next, we determined the eﬀect of HFD feeding on the
expression of signaling molecules known to regulate insulin
sensitivity (see Figure 4 and Table 2). Consistent with unal-
tered plasma adiponectin levels after one week and reduced
plasmaadiponectinlevelsafter16wHFDfeeding,themRNA
levels of the adiponectin gene (Adipoq) in adipose tissue
were not changed after one week and signiﬁcantly reduced
after 16 w HFD feeding (see Figure 4). Adipoq levels in
liver showed a similar temporal pattern upon HFD feeding,
however expression was very low compared to adipose tissue
(see Table 2). Expression of the insulin-responsive glucose
transporter Glut4 (also known as Slc2a4) was induced 6-fold
after 1 w HFD in adipose tissue and returned to basal levels
after 16 w HFD while in muscle it was moderately but
signiﬁcantly suppressed already after 1 w HFD (see Table 2).
The expression of insulin receptor substrate-1 (Irs1)w a s
largely unaﬀected in liver and skeletal muscle while it was
progressively down-regulated in adipose tissue. By contrast,
Irs2 expression was reduced in all three tissues in a tissue-
speciﬁc manner (see Figure 4 and Table 2).
To examine potential HFD-mediated tissue speciﬁc shifts
in metabolic capacity, we determined the expression of
PGC-1α and PGC-1β, two transcriptional regulators of
mitochondriogenesis and oxidative metabolism. As shown
in Figure 4 and Table 2, Pgc1a expression was signiﬁcantly
reduced after 1 w HFD in liver and recovered to control
levels after 16 w HFD. In adipose tissue and skeletal muscle,
only a trend towards downregulation could be observed. The
expression of Pgc1b was upregulated in liver and skeletal
muscle after 16 w HFD with a trend towards upregulation
evident already after 1 w HFD in liver. In adipose tissue,
Pgc1b was reduced after 1 w HFD diet and expression was
further impaired after 16 w HFD.
In summary, signiﬁcant tissue-speciﬁc downregulation
of genes critical for maintaining insulin sensitivity was
observed in the HFD-fed mice.
3.5. EffectsofrecombinantA-SAAongeneexpression
andmetabolismin3T3-L1adipocytes
The observed concurrence of elevated plasma A-SAA with
hyperinsulinemia in this mouse model prompted us to
study a potential causal role of A-SAA in the development
of peripheral insulin resistance, using diﬀerentiated 3T3-
L1 cells as a model system. Treatment with physiological
concentrations of recombinant A-SAA for 24 hours led to a
pronounced induction of Ccl2 and Saa3 in a dose-dependent
manner (see Figure 5).
These eﬀects were unlikely to be caused by endotoxin
contamination of the A-SAA preparation, as they were
unaﬀected by the addition of the endotoxin neutralizer
polymyxin B (see Figure 5 and [29]). In contrast, genes
involved in insulin signaling, glucose transport, and mito-
chondriogenesis (Adipoq, Irs1, Glut4, Pgc1a, Pgc1b)w e r e
signiﬁcantly downregulated by A-SAA in a degree similar to
TNFα treatment (see Figure 5). Interestingly, the alterations
in 3T3-L1 gene expression resembled but were not identical
to those observed in vivo in adipose tissue after chronic HFD
feeding(seeFigure 4).Speciﬁcally,Irs2 wasdownregulatedin
vivo but not in vitro, while Glut4 was downregulated in vitro
but not in vivo.Ludger Scheja et al. 7
Table 2: Expression of inﬂammatory genes and genes related to insulin sensitivity in liver, adipose tissue and skeletal muscle of HFD-fed
mice. Data are reported as copy number relative to 104 copies of house keeper. Numbers of animals (n) are in parentheses. Data are mean
±SEM; ∗P<. 05 versus Chow, ∗∗P<. 01 versus Chow, (a)P<. 05 versus 1w HFD, (b)P<. 01 versus 1w HFD; two-tailed Student’s t-test.
Experimental Groups Chow 1w HFD 16w HFD
Copy number Copy number Copy number
Liver
Ccl2 590 ± 179 (6) 1,813 ± 692 (6) 4,769 ± 677 (6)∗∗(a)
Cxcl1 2,074 ± 529 (6) 4,465 ± 1,016 (6) 13,709 ± 1,489 (6)∗∗(b)
Cd68 8,969 ± 880 (6) 13,192 ± 1,621 (6)∗ 28,417 ± 3,828 (6)∗∗(b)
Cd11b 2,129 ± 223 (6) 1,300 ± 278 (6)∗ 2,317 ± 156 (6)(b)
Emr1 2,789 ± 588 (6) 3,525 ± 646 (6) 5,186 ± 977 (6)
Adipoq 61 ± 23 (6) 67 ± 11 (6) 33 ± 3( 6 ) (a)
Glut4 80 ± 15 (6) 84 ± 15 (6) 212 ± 44 (6)∗(a)
Insr 9,416 ± 1,909 (4) 5,795 ± 223 (4) 7,275 ± 380 (4)(a)
Irs1 19,376 ± 1,196 (6) 20,830 ± 905 (6) 18,087 ± 355 (6)(a)
Irs2 55,531 ± 4,549 (6) 31,257 ± 4,180 (6)∗∗ 13,435 ± 832 (6)∗∗(b)
Pgc1a 7,065 ± 1,584 (6) 3,357 ± 460 (6)∗ 6,348 ± 559 (6) (b)
Pgc1b 6,257 ± 1,012 (6) 9,217 ± 1,576 (6) 12,543 ± 1,083 (6)∗∗
Adipose tissue
Ccl2 10,700 ± 6,564 (5) 6,628 ± 628 (5) 32,055 ± 8,522 (6)(a)
Cxcl1 1,861 ± 752 (6) 802 ± 129 (6) 1,859 ± 284 (6)(b)
Cd68 51,947 ± 5,446 (6) 92,213 ± 15,472 (6)∗ 1,492,178± 435,981(6)∗∗(b)
Cd11b 19,011 ± 3,357 (6) 35,227 ± 4,969 (6)∗ 227,310 ± 49,105 (6)∗∗(b)
Emr1 2,187 ± 381 (6) 6,618 ± 1,032 (6)∗∗ 55,752 ± 7,298 (6)∗∗(b)
Adipoq 1,658,946 ± 598,784 (6) 2,028,698 ± 485,799 (6) 803,801 ± 248,995 (6)(a)
Glut4 19,418 ± 6,662 (6) 78,678 ± 11,679 (6)∗∗ 25,965 ± 7,010 (6)(b)
Insr 18,149 ± 2,080 (4) 17,441 ± 1,248 (4) 13,880 ± 477 (4)(a)
Irs1 60,068 ± 12,861 (6) 36,282 ± 2,983 (6) 11,888 ± 2,316 (6)∗∗(b)
Irs2 88,190 ± 14,430 (6) 81,351 ± 6,149 (6) 24,811 ± 3,661 (6)∗∗(b)
Pgc1a 1,776 ± 441 (6) 1,009 ± 87 (6) 1,070 ± 388 (6)
Pgc1b 7,558 ± 1,261 (5) 6,282 ± 737 (4) 4,042 ± 299 (5)∗(a)
Skeletal muscle
Ccl2 204 ± 46 (6) 554 ± 131 (6)∗ 1,224 ± 111 (6)∗∗(b)
Cxcl1 89 ± 9 (6) 70 ± 13 (6) 129 ± 15 (6)∗(a)
Cd68 3,927 ± 643 (6) 4,237 ± 445 (6) 10,178 ± 422 (6)∗∗(b)
Cd11b 2,239 ± 361 (6) 3,463 ± 521 (6) 3,956 ± 773 (6)
Emr1 387 ± 25 (6) 421 ± 57 (6) 724 ± 41 (6)∗∗(b)
Adipoq 94,837 ± 17,077 (6) 116,610 ± 56,998 (6) 114,194 ± 19,422 (6)
Glut4 512,548 ± 27,756 (6) 379,390 ± 30,641 (6) ∗∗ 423,423 ± 22,047 (6)∗
Insr 57,791 ± 2,283 (6) 42,298 ± 1,673 (6) ∗∗ 50,984 ± 2,188 (6)(a)
Irs1 58,141 ± 7,790 (6) 45,326 ± 6,154 (6) 47,738 ± 5,014 (6)
Irs2 51,152 ± 9,399 (6) 27,292 ± 4,061 (6)∗ 21,470 ± 1,374 (6)∗
Pgc1a 39,951 ± 24,961 (6) 17,510 ± 8,171 (6) 12,085 ± 1,107 (6)
Pgc1b 6,003 ± 1,476 (6) 7,408 ± 1,327 (6) 10,150 ± 271 (6)∗
Next, we checked whether the observed changes in gene
expression had eﬀects on glucose transport, an important
insulin-regulated metabolic function of adipocytes. Treat-
ment of 3T3-L1 adipocytes with A-SAA for 24 hours had
no signiﬁcant eﬀect on insulin-stimulated glucose transport
either at submaximal or maximum insulin concentrations
(data not shown).
4. DISCUSSION
We report here the eﬀect of HFD feeding on SAA in the
insulin resistance- and obesity-prone mouse strain C57Bl/6.
Short-term HFD feeding (1 w HFD) resulted in a moderate
but signiﬁcant increase in fasting plasma insulin, glucose
and leptin, indicating incipient, and mild insulin resistance8 Experimental Diabetes Research
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Figure 5: Eﬀects of recombinant A-SAA and TNFα on gene expression in diﬀerentiated 3T3-L1 adipocytes. (a) Dose-dependent induction
of Saa3 and Ccl2 by recombinant A-SAA. Diﬀerentiated 3T3-L1 adipocytes were washed with PBS and starved overnight in DMEM
containing 0.1% BSA. Subsequently, cells were treated for 24 hours with various concentrations of recombinant A-SAA (0, 0.125 1.25, 12.5,
25μg/mL). (b) Regulation of signaling genes by A-SAA and TNFα:D i ﬀerentiated 3T3-L1 adipocytes were treated as described under (a) and
subsequently incubated with A-SAA (12.5μg/mL, closed bars) and TNFα (10ng/mL, hatched bars) for 24 hours. (c) Eﬀect of polymyxin
B (PMB) on induction of Saa3 and Ccl2.P M Ba t1 0μg/mL was added alone or in combination with lipopolysaccharide (LPS, 2.5ng/mL)
and A-SAA (1.25μg/mL), respectively. Experimental conditions were as described under (a). Copy numbers are relative to one copy of TBP
mRNA.Representativedatafromatleastthreeindependentexperimentsareshown.Dataaremean ±standarddeviationrelativetountreated
controls.
in this group. The chronically fed group (16 w HFD)
was severely insulin resistant, as shown by elevated fasting
plasma insulin, glucose and leptin, and reduced adiponectin
levels. In order to relate the observed insulin resistance
to inﬂammatory processes, we measured plasma levels of
A-SAA and found that these were already elevated after
one week of HFD, further increasing after 16 weeks of
HFD feeding. A correlation of plasma A-SAA with insulin
resistance and obesity in humans has been reported by
several groups, however, acute phase proteins as markers or
mediators of insulin resistance have not been addressed in
animal models so far. We show for the ﬁrst time that plasma
A-SAA is associated with obesity and insulin resistance in the
frequently used DIO mouse model. Therefore, this model
may be useful to unravel molecular mechanisms relating to
A-SAA and its potential signiﬁcance to insulin resistance.
In order to determine the contribution of metabolically
relevant tissues to the diet-induced rise in plasma A-SAA, we
quantiﬁed the expression of SAA genes. The expression of
the genes corresponding to A-SAA, Saa1,a n dSaa2,i nl i v e r
correlated with plasma A-SAA, while in adipose tissue and
muscle expression of the A-SAA isoforms was very low and
no induction by HFD was observed. This is in contrast to
recently published human studies which reported that the
elevation of plasma A-SAA in metabolic disease is linked
to induction of Saa1 and Saa2 in adipose tissue [9, 12]b u t
apparently not in liver [11]. In adipose tissue of the HFD-fed
mice, the Saa3 gene was highly induced suggesting that in
mouse adipose tissue SAA3 plays a role similar to adipose A-
S A Ai nh u m a n sw h od on o th a v eaf u n c t i o n a lSaa3 gene [4].
Further experiments with regardto Saa3gene regulation and
functions in murine adipose tissue are needed to understandLudger Scheja et al. 9
how closely murine adipose Saa3 relates to Saa1 and Saa2 in
human adipose tissue.
T h et i s s u es p e c i ﬁ ca n dt e m p o r a lp a t t e r no fS A Ae x p r e s -
sion prompted us to further delineate the inﬂammatory
responses in the tissues of the insulin resistant mice by
assessing the expression of inﬂammatory mediators as well
as expression of myeloid cell surface markers as indicators
of macrophage activation and inﬁltration. These were then
put into relation to plasma A-SAA levels and to the observed
SAA expression patterns. In agreement with published data
[1, 21, 22], fully insulin resistant mice (16 w HFD) showed
a substantial induction in adipose tissue of the cytokine Tnf,
thechemokineCcl2aswellasthemacrophagemarkersCd68,
Cd11b, and Emr1.I nl i v e ra n di nm u s c l e ,Tnf and Ccl2
expressions were also induced, however, less pronounced
than in adipose tissue while the macrophage markers were
only partially and moderately induced in these tissues. One
exceptionwasCd68which,likethechemokineCxcl1,showed
an expression pattern similar to Saa1 and Saa2 in liver
suggesting that they may be regulated in a similar manner
as the A-SAA isoforms. After one week of HFD feeding,
moderate but signiﬁcant induction of all three macrophage
markers was observed in adipose tissue, but not in the
othertissues,indicatingthatadiposemacrophageinﬁltration
[21, 22] is an early event related to HFD-induced insulin
resistance. Expression of the chemokine CCL2, which has
been implicated in obesity-linked macrophage inﬁltration
[23],was,however,notelevatedinfatatthisstage.Thesedata
suggest that other chemoattractants may play an important
role in the early phase of adipose macrophage inﬁltration,
while CCL2 may be more important at later stages of
obesity-induced adipose tissue inﬂammation. SAA3 which
was profoundly induced in the 1 w HFD group and which
has very recently been shown to exert chemotactic activity
on monocytes [30] may actually be such a chemoattractant
conferring initiation of macrophage inﬁltration in adipose
tissue.ExpressionofSaa3inadipocytesissensitivetoinﬂam-
m a t o r ys t i m u l ia sw e l la sn u t r i e n to v e r ﬂ o w[ 31], making it a
good candidate for the induction of macrophage inﬁltration
in adipose tissue. Studies involving loss of function of SAA3
or the not yet identiﬁed SAA3 receptor responsible for
macrophage attraction are needed to deﬁnitely address the
role of SAA3 in insulin resistant adipose tissue.
In light of the observations that adipose tissue exhibited
the ﬁrst detectable inﬂammatory response under HFD
feeding, and that plasma A-SAA correlates with the degree
of insulin resistance, we asked whether there may be a
direct induction of insulin resistance in adipocytes by A-
SAA. For this purpose, we incubated 3T3-L1 adipocytes with
recombinant A-SAA and used the expression of inﬂamma-
tory markers and signaling genes as indicators for insulin
resistance. Intriguingly, physiological A-SAA concentrations
led to an induction of Saa3 and downregulation of selected
signaling genes linked to insulin sensitivity such as Adipoq,
Glut4, Irs1, Pgc1a,a n dPgc1b. Reduction of these genes,
with the exception of Glut4 and Pgc1a, was also detected in
adipose tissue of the insulin resistant mice after 16 weeks
on the HFD. However, insulin-stimulated glucose transport
was not altered after A-SAA treatment in our experiments
suggesting that A-SAA alone is not suﬃcient to induce
impaired insulin signaling in adipocytes. Interestingly, in
contrast to adipose tissue after chronic HFD feeding, the
expression of Irs2 in the 3T3-L1 adipocytes was unaltered
which is likely explaining the preserved insulin sensitivity.
Nevertheless, it is conceivable that A-SAA secreted from the
liver potentiates inﬂammatory and insulin desensitization
processes in adipose tissue. This mechanism would likely
be more important in an early phase of insulin resistance,
comparabletoour1wHFDgroup,whentissueexpressionof
inﬂammatory regulators such as TNFα, which is well known
tohavetheeﬀectsdescribedaboveonadipocytes[32,33]and
mediates insulin resistance in vivo [1], is not yet signiﬁcantly
induced.
What could be the primary factor causing A-SAA induc-
tion in liver? Known inducers of the A-SAA isoforms in this
tissue are the cytokines IL-1β,I L - 6 ,a n dT N F α [3, 13]. Only
the latter was induced to a meaningful degree in liver in our
study, with a strong rise after 16 weeks on the HFD, however,
no change compared to the controls after one week on the
HFD. Since we found no signiﬁcant change in expression of
these cytokines in the other tissues investigated, it is unlikely
that either of these cytokines plays a role in the early rise of
Saa1 and Saa2 in liver, and hence the elevation of plasma A-
SAA.
An alternative mechanism of SAA elevation in liver
is lipid overload. Evidence for a role of lipids in A-SAA
induction was provided in dietary studies with mouse
atherosclerosis models showing an induction of Saa1, Saa2,
and Saa3 in liver by atherogenic diets containing high fat and
high cholesterol [24, 25, 34]. Similarly, in humans plasma A-
SAA could be induced by a high-cholesterol diet [35]. Since
the diet used in our experiment also contained cholesterol,
albeit less than in a typical atherogenic diet, it is possible that
cholesterol played an important role here as well. However,
in our study total liver cholesterol and triglycerides were not
elevated in the 1 w HFD group (data not shown), arguing
against a simple lipid overload mechanism. Clearly, more
studies are warranted to unravel the nutritional mechanism
of SAA induction in humans and animal models in order
to understand its respective contributions to atherosclerosis
and impaired glucose metabolism as well as its value as a
clinical biomarker.
Taken together, we show that in the commonly used
DIO mouse model plasma A-SAA levels are associated with
insulin resistance. Our data indicate that A-SAA elevation is
due to Saa1 and Saa2 induction in liver but not, as reported
for humans, in adipose tissue. Also, we identify Saa3 as
a strong candidate for mediating the initiation of adipose
tissue inﬂammation in HFD-induced obesity. Furthermore,
we found that recombinant A-SAA at physiological concen-
trations regulates gene expression in cultured adipocytes in a
fashion similar to insulin resistant adipose tissue, suggesting
that A-SAA might be a contributor to the development of
insulin resistance and not merely a marker of inﬂammation.
Future experiments will be directed towards the triggering
mechanisms for SAA induction in liver and adipose tissue,
and the importance of adipose tissue derived SAA3 in
provoking inﬂammatory responses and insulin resistance.10 Experimental Diabetes Research
ABBREVIATIONS
A-SAA: Acute-phase serum amyloid A
CCL2: Chemokine (C-C motif) ligand 2
CXCL1: Chemokine (C-X-C motif) ligand 1
DIO: Diet induced obesity
HFD: High-fat diet
IBMX: 3-isobutyl 3-methylxanthine
PGC: Peroxisome proliferator activated receptor-γ
coactivator
PPAR: Peroxisome proliferator activated receptor
SAA: Serum amyloid A
TBP: TATA box binding protein
1 w HFD: One week of HFD
16 w HFD: 16 weeks of HFD
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